Literature DB >> 17336596

Analysis of DNA repair and recombination responses in mouse cells depleted for Brca2 by SiRNA.

Shauna A Lee1, Mark D Baker.   

Abstract

The tumor suppressor BRCA2 is considered to play an important role in the maintenance of genome integrity through the repair of DNA lesions by homologous recombination. A mechanistic understanding of BRCA2 has been complicated by the embryonic lethality of mice bearing allelic knockouts of Brca2, and by variation in the DNA damage response in cells bearing BRCA2 deficiencies. It would be advantageous to develop approaches that avoid the cell lethality associated with complete inactivation of the gene, or the use of established tumor cell lines in which other genes in addition to BRCA2 may be mutant. In this study, SiRNA was used in stable transformation assays to knockdown Brca2 in mouse hybridoma cells by at least 75%. The Brca2-depleted cells were analyzed with respect to cell growth, sensitivity to DNA damaging agents (mitomycin C, methylmethane sulfonate, or ionizing radiation), intrachromosomal homologous recombination and gene targeting. Although the effect of Brca2-depletion on cell growth and sensitivity to DNA damaging agents was modest, the Brca2-depleted cells did show a significant shift in homologous recombination from gene conversion to single-strand annealing and a significant decrease in the efficiency of gene targeting. Both of these phenotypes are consistent with the proposed role of Brca2 in DNA repair and recombination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336596     DOI: 10.1016/j.dnarep.2007.01.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  3 in total

1.  Nascent DNA synthesis during homologous recombination is synergistically promoted by the rad51 recombinase and DNA homology.

Authors:  Maureen M Mundia; Vatsal Desai; Alissa C Magwood; Mark D Baker
Journal:  Genetics       Date:  2014-02-28       Impact factor: 4.562

2.  Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.

Authors:  Sailesh Gochhait; Syed Irfan Ahmad Bukhari; Narendra Bairwa; Shivani Vadhera; Katayoon Darvishi; Mohammad Raish; Pawan Gupta; Syed Akhtar Husain; Rameshwar N K Bamezai
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

3.  Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.

Authors:  Andri Rezano; Kazuhiko Kuwahara; Mutsuko Yamamoto-Ibusuki; Masahiro Kitabatake; Penpak Moolthiya; Suchada Phimsen; Taiji Suda; Shigenobu Tone; Yutaka Yamamoto; Hirotaka Iwase; Nobuo Sakaguchi
Journal:  BMC Cancer       Date:  2013-12-01       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.